Advertisement

Topics

‘Landmark’ day for Akcea as NICE recommends Tegsedi in rare inherited hATTR

06:35 EDT 17 Apr 2019 | PharmaTimes

The decision will allow patients in England with the rare, inherited, severely debilitating and fatal disease to access the treatment on the NHS.

Original Article: ‘Landmark’ day for Akcea as NICE recommends Tegsedi in rare inherited hATTR

NEXT ARTICLE

More From BioPortfolio on "‘Landmark’ day for Akcea as NICE recommends Tegsedi in rare inherited hATTR"

Advertisement
Quick Search
Advertisement
Advertisement